Nuclear factor-κB - importance, induction of inflammation, and effects of pharmacological modulators in Crohn's...

Area of Science:

• Gastroenterology
• Immunology
• Molecular Biology

Background:

• Crohn's disease (CD) is a chronic inflammatory condition affecting the entire digestive tract with unclear origins.
• Its incidence is increasing globally, particularly in Asian countries, necessitating a deeper understanding of its pathogenesis.
• Genetic, immune, and microbiota factors are implicated, with aberrant nuclear factor kappa B (NF-κB) signaling identified as a key driver.

Purpose of the Study:

• To review the epidemiology and pathogenesis of Crohn's disease.
• To elucidate the role of the NF-κB signaling pathway in CD initiation and progression.
• To discuss current and novel therapeutic strategies targeting NF-κB activation in CD.

Main Methods:

• Literature review focusing on Crohn's disease, NF-κB signaling, and therapeutic interventions.
• Analysis of studies investigating the link between NF-κB activation and pro-inflammatory cytokine production in CD.
• Examination of treatments that modulate NF-κB activity, such as mesalazine and glucocorticoids.

Main Results:

• NF-κB signaling is critically involved in the chronic intestinal inflammation characteristic of CD.
• Excessive pro-inflammatory cytokine production, driven by NF-κB, contributes to CD pathogenesis.
• Existing treatments like mesalazine and glucocorticoids have demonstrated the ability to reduce NF-κB activation.

Conclusions:

• The NF-κB pathway is a central player in Crohn's disease pathogenesis.
• Targeting NF-κB activation represents a promising therapeutic avenue for managing CD.
• Further research into NF-κB inhibitors may lead to more effective treatments for this chronic inflammatory condition.